Gyre Therapeutics (GYRE) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.86% |
| Dec 31, 2025 | 53.09% |
| Sep 30, 2025 | 15.49% |
| Jun 30, 2025 | 14.93% |
| Mar 31, 2025 | 16.08% |
| Dec 31, 2024 | 74.73% |
| Sep 30, 2024 | 14.98% |
| Jun 30, 2024 | 15.27% |
| Mar 31, 2024 | 15.68% |
| Dec 31, 2023 | -10.61% |
| Sep 30, 2023 | 15.93% |
| Jun 30, 2023 | 15.50% |
| Mar 31, 2023 | 15.68% |
| Dec 31, 2022 | -5.92% |
| Sep 30, 2022 | 34.63% |
| Jun 30, 2022 | 21.50% |
| Mar 31, 2022 | 36.82% |
| Dec 31, 2021 | 32.74% |
| Sep 30, 2021 | 33.26% |
| Jun 30, 2021 | 36.77% |
| Mar 31, 2021 | 30.03% |
| Dec 31, 2020 | -14.35% |
| Sep 30, 2020 | 4.73% |
| Jun 30, 2020 | 26.90% |
| Mar 31, 2020 | 48.42% |
| Dec 31, 2019 | 20.28% |
| Sep 30, 2019 | 23.63% |
| Jun 30, 2019 | 27.34% |
| Mar 31, 2019 | 23.31% |
| Dec 31, 2018 | -18.38% |
| Sep 30, 2018 | -10.99% |
| Jun 30, 2018 | -7.85% |
| Mar 31, 2018 | -18.47% |
| Dec 31, 2017 | -15.35% |
| Sep 30, 2017 | -41.05% |
| Jun 30, 2017 | -51.13% |
| Mar 31, 2017 | -132.05% |
| Dec 31, 2016 | -74.19% |
| Sep 30, 2016 | -86.18% |
| Jun 30, 2016 | -146.18% |
| Mar 31, 2016 | -66.91% |
| Dec 31, 2015 | -41.26% |
| Sep 30, 2015 | -65.28% |
| Jun 30, 2015 | -106.32% |